China Universal Asset Management Company’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $235K | Buy |
8,503
+77
| +0.9% | +$2.13K | 0.02% | 296 |
|
|
2025
Q1 | $187K | Sell |
8,426
-388
| -4% | -$8.62K | 0.02% | 319 |
|
|
2024
Q4 | $174K | Buy |
8,814
+1,004
| +13% | +$19.9K | 0.02% | 337 |
|
|
2024
Q3 | $195K | Buy |
7,810
+3,076
| +65% | +$76.9K | 0.02% | 304 |
|
|
2024
Q2 | $88.4K | Sell |
4,734
-2,974
| -39% | -$55.5K | 0.01% | 309 |
|
|
2024
Q1 | $152K | Buy |
7,708
+3,611
| +88% | +$71.2K | 0.02% | 327 |
|
|
2023
Q4 | $71.9K | Buy |
4,097
+3,186
| +350% | +$55.9K | 0.01% | 324 |
|
|
2023
Q3 | $15.8K | Buy |
911
+453
| +99% | +$7.87K | ﹤0.01% | 314 |
|
|
2023
Q2 | $6.45K | Sell |
458
-10
| -2% | -$141 | ﹤0.01% | 345 |
|
|
2023
Q1 | $5.04K | Buy |
468
+117
| +33% | +$1.26K | ﹤0.01% | 365 |
|
|
2022
Q4 | $5.26K | Buy |
351
+28
| +9% | +$419 | ﹤0.01% | 293 |
|
|
2022
Q3 | $4K | Buy |
+323
| New | +$4K | ﹤0.01% | 301 |
|